Alternative
Medicinals
The rapid
rise of alternative therapies and the growing trend to self
medication present a $18 billion opportunity for companies in
the life sciences and healthcare industries. But are alternatives
everyone’s cup of tea? Not all corporate cultures may be open
to the alternative revolution. Regardless, though, all companies
need to assess the very real competitive threat posed by alternative
therapies. And those companies that are willing to explore the
possibilities need help charting a complementary path. Meanwhile,
companies within the field are facing some of the same challenges
that confront traditional pharmaceutical companies, i.e. developing
growth strategies, new products, increased consolidation, and
regulatory scrutiny, as well as other challenges unique to the
industry.
Case
study: An Alternative Complement
|
Home | About BDF | Capabilities
| Expertise | Case
Studies |
| BDF Report | Challenge
Us | Employment | Contact
|
©
2001 Bogart Delafield Ferrier, LLC
